Author:
Pogue Gregory P.,Swope Kelsi,Rininger Joseph,Schoukroun-Barnes Lauren,Morton Josh,Hume Steve,Hamorsky Krystal,Fuqua Josh,Royal Joshua M.,Pauly Michael H.,Brennan Max,Zeitlin Larry,Whaley Kevin,Stevens Sean,Bratcher Barry
Publisher
Springer Nature Singapore
Reference49 articles.
1. Alam A, Jiang L, Kittleson GA, Steadman KD, Nandi S, Fuqua JL et al (2018) Technoeconomic modeling of plant-based Griffithsin manufacturing. Front Bioeng Biotechnol 6:1–13
2. Antibody Society (2022) Antibody therapeutics approved or in regulatory review in the EU or US - The Antibody Society. https://www.antibodysociety.org/resources/approved-antibodies/. Accessed 8 Apr 2023
3. Bakker HAC, Jan HB (2010) Mammalian-type glycosylation in plants. Glycobiology 1:1–22
4. Bardor M, Faveeuw C, Fitchette AC, Gilbert D, Galas L, Trottein F et al (2003) Immunoreactivity in mammals of two typical plant glyco-epitopes, core α(1,3)-fucose and core xylose. Glycobiology 13:427–434
5. Barone PW, Wiebe ME, Leung JC, Hussein ITM, Keumurian FJ, Bouressa J et al (2020) Viral contamination in biologic manufacture and implications for emerging therapies. Nat Biotechnol 38:563–572